Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Vaccines”

2,658 trials

Showing 20 of 2,658 results

Testing effectiveness (Phase 2)Study completedNCT00415051
What this trial is testing

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 20
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Post-approval studies (Phase 4)Study completedNCT03183765
What this trial is testing

Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts

Who this might be right for
Common WartPlantar Wart
Assiut University 48
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Testing effectiveness (Phase 2)Study completedNCT01155037
What this trial is testing

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults

Who this might be right for
HIV Infection
Oswaldo Cruz Foundation 450
Early research (Phase 1)Study completedNCT03827395
What this trial is testing

Safety Study of Hepatitis E Vaccine (HEV239)

Who this might be right for
Hepatitis EImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 25
Post-approval studies (Phase 4)Study completedNCT00289757
What this trial is testing

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule

Who this might be right for
Hepatitis A
GlaxoSmithKline 78
Large-scale testing (Phase 3)WithdrawnNCT06567457
What this trial is testing

Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty
Large-scale testing (Phase 3)Study completedNCT00595309
What this trial is testing

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 198
Not applicableStudy completedNCT00050063
What this trial is testing

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 78
Post-approval studies (Phase 4)Study completedNCT00774995
What this trial is testing

Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.

Who this might be right for
Hepatitis B
GlaxoSmithKline 49
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Early research (Phase 1)Study completedNCT03391375
What this trial is testing

Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial

Who this might be right for
HIV/AIDS
EuroVacc Foundation 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT03036930
What this trial is testing

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Who this might be right for
Human Papillomavirus InfectionHuman Papillomavirus-Related Carcinoma
National Cancer Institute (NCI) 51
Early research (Phase 1)Study completedNCT00000632
What this trial is testing

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 14
Early research (Phase 1)Looking for participantsNCT07530198
What this trial is testing

HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong

Who this might be right for
Human Immunodeficiency VirusHuman Immunodeficiency Virus I Infection
Immuno Cure Holding (HK) Limited 22
Testing effectiveness (Phase 2)WithdrawnNCT05016934
What this trial is testing

Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized

Who this might be right for
Covid19
Hospital do Coracao
Large-scale testing (Phase 3)Study completedNCT04904471
What this trial is testing

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 39,663
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT04537949
What this trial is testing

A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults

Who this might be right for
Covid-19Protection Against COVID-19
BioNTech SE 96
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation